OTC Medication Information: Alahist D

ALAHIST D- pheniramine maleate and phenylephrine hydrochloride tablet
Poly Pharmaceuticals, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

ACTIVE INGREDIENT

Active Ingredient (in each tablet) Purpose

Pheniramine Maleate 17mg​

Antihistamine
Phenylephrine HCl 10mg Nasal Decongestant

USES

Temporarily relieves these symptoms due to the
common cold, hay fever (allergic rhinitis) or other
upper respiratory allergies:

  •  runny nose
  •  sneezing
  •  itching of the nose or throat
  •  itchy, watery eyes
  •  nasal congestion 
    • reduces swelling of nasal passages

WARNINGS

Do not exceed recommended dosage.

Do not use this product  if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or
emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

  •  a breathing problem such as emphysema or chronic bronchitis
  •  glaucoma
  •  trouble urinating due to enlargement of the prostate gland
  •  heart disease
  •  high blood pressure
  •  thyroid disease 
  • diabetes

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

When using this product

  •  excitability may occur, especially in children
  •  may cause drowsiness
  •  avoid alcoholic drinks
  •  alcohol, sedatives, and tranquilizers may increase the drowsiness effect
  •  use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if
 nervousness, dizziness, or sleeplessness occur
 symptoms do not improve within 7 days or are accompanied by fever

If pregnant or breast-feeding, ask a health professional before use.

DIRECTIONS

Directions

Adults and children 12 years of age and over 1 tablet every 4 hours, not to exceed 6 tablets in 24 hours

Children 6 to under 12 years of age

Children under 6 consult a doctor

1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours

INACTIVE INGREDIENTS

Inactive ingredients
Magnesium Stearate, Microcrystalline Cellulose, Natural Yellow, Sodium Starch Glycolate

QUESTIONS

Questions? Comments?
Call 1-800-882-1041
Manufactured for:
Poly Pharmaceuticals
Huntsville, AL 35763 Rev. 04/17

OTHER INFORMATION

Other information
Store at 15°-30°C (59°-86°F). Supplied in a tight, light-resistant container with a child-resistant cap. Alahist D Tablets are yellow,debossed “A” bisect “D” on one side and plain on the other.

​Keep out of reach of children

​In case of overdose, get medical help or contact a Poison Control Center right away.

Antihistamine

Nasal Decongestant

Package Label

label
(click image for full-size original)

INSERT
(click image for full-size original)
ALAHIST D
pheniramine maleate, phenylephrine hcl tablet
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:50991-776
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PHENIRAMINE MALEATE (PHENIRAMINE) PHENIRAMINE MALEATE 17.5 mg
PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE) PHENYLEPHRINE HYDROCHLORIDE 10 mg
Inactive Ingredients
Ingredient Name Strength
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
FERRIC OXIDE YELLOW
SODIUM STARCH GLYCOLATE TYPE A CORN
Product Characteristics
Color yellow Score 2 pieces
Shape OVAL Size 11mm
Flavor Imprint Code A;D
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50991-776-01 100 TABLET in 1 BOTTLE None
2 NDC:50991-776-02 12 TABLET in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 04/01/2020
Labeler — Poly Pharmaceuticals, Inc. (198449894)

Revised: 01/2024 Poly Pharmaceuticals, Inc.

Our database comes directly from the FDA’s central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA’s repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. OTCLabels.com provides the full over the counter products subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2024. All Rights Reserved.